• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: zinflavonoids
Date Designated: 01/07/2021
Orphan Designation: Treatment of anatomical sites of squamous cell carcinoma of oral cavity and oropharynx accessible for local and topical administration
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Aveta Biomics, Inc.
110 Great Road
Suite 302
Bedford, Massachusetts 01730
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-